Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 12, 2012
Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
Jinho Park, Sunghyun Kim, Phei Er Saw, et al.
British Journal of Pharmacology
|
April 11, 2024
BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice
Hyemi Lee, Jiho Nam, Hahyeong Jang, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 10, 2019
Subacute toxicity and toxicokinetics study of DHP107, an oral paclitaxel formulation with once-weekly dosing in mice
Ji-Young Kim, Sunyeong Lee, Yongbum Kim, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy
Jinho Park, Seho Park, Sunghyun Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 15, 2025
KB-0118, A novel BET bromodomain inhibitor, suppresses Th17-mediated inflammation in inflammatory bowel disease
Yeo-Jin Jeong, Yeon-Su Ok, Gi-Nam Kwon, et al.
Frontiers in Immunology
|
August 18, 2025
A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling
Hyemi Lee, Seong Jae Han, Subin Ok, et al.
Nano Letters
|
October 22, 2014
A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins
Won Il Choi, Nazila Kamaly, Lorena Riol-Blanco, et al.
Advanced Healthcare Materials
|
July 22, 2017
Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr<sup>-/-</sup> Mice
Mikyung Yu, Jaume Amengual, Arjun Menon, et al.
Clinical and Translational Science
|
June 4, 2021
Tissue pharmacokinetics of DHP107, a novel lipid-based oral formulation of paclitaxel, in mice and patients by positron emission tomography
Byung Seok Moon, Hyun Soo Park, Jung Sunwoo, et al.
Theranostics
|
January 8, 2019
Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery
Mikyung Yu, Carleena A Ortega, Kevin Si, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 12, 2012
Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
Jinho Park, Sunghyun Kim, Phei Er Saw, et al.
British Journal of Pharmacology
|
April 11, 2024
BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice
Hyemi Lee, Jiho Nam, Hahyeong Jang, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 10, 2019
Subacute toxicity and toxicokinetics study of DHP107, an oral paclitaxel formulation with once-weekly dosing in mice
Ji-Young Kim, Sunyeong Lee, Yongbum Kim, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy
Jinho Park, Seho Park, Sunghyun Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 15, 2025
KB-0118, A novel BET bromodomain inhibitor, suppresses Th17-mediated inflammation in inflammatory bowel disease
Yeo-Jin Jeong, Yeon-Su Ok, Gi-Nam Kwon, et al.
Frontiers in Immunology
|
August 18, 2025
A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling
Hyemi Lee, Seong Jae Han, Subin Ok, et al.
Nano Letters
|
October 22, 2014
A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins
Won Il Choi, Nazila Kamaly, Lorena Riol-Blanco, et al.
Advanced Healthcare Materials
|
July 22, 2017
Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr<sup>-/-</sup> Mice
Mikyung Yu, Jaume Amengual, Arjun Menon, et al.
Clinical and Translational Science
|
June 4, 2021
Tissue pharmacokinetics of DHP107, a novel lipid-based oral formulation of paclitaxel, in mice and patients by positron emission tomography
Byung Seok Moon, Hyun Soo Park, Jung Sunwoo, et al.
Theranostics
|
January 8, 2019
Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery
Mikyung Yu, Carleena A Ortega, Kevin Si, et al.
Page
of 3